Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Singular Health Group Ltd

Company price
0.205 AUD 0.01 ( 2.50%)
Last update at 2026-11-12T05:10:00Z
VOLUME
11704
Market Cap
71.74M

Momentum Score

…

Singular Health Group Ltd, operates as a healthcare technology company in Australia. The company Volumetric Rendering Platform, a proprietary technology that enhances the visualization of patient anatomy and health issues by converting 2D images from CT, MRI, and PET scans into 3D models. It also provides Medical File Transfer Protocol, a technology that streamlines the access, sharing, and storage of medical images, such as CT, MRI, and PET scans across electronic devices and healthcare providers. In addition, the company offers AI in the Cloud that enhances medical imaging by integrating AI models. Further, it provides 3DICOM MD for healthcare professionals; 3DICOM EDU and XR for academics and researchers; and 3DICOM Patient for patients. Additionally, the company is involved in development and commercialization of the 3DICOM platform; enterprise healthcare imaging/interoperability solutions; education applications; and associated regulatory and product-development activities. Singular Health Group Ltd was incorporated in 2020 and is based in Leederville, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.20
Low
0.20
High
52 Week Price Range
0.14
Low
0.30
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Singular Health Group Ltd is an Australian medical technology company that develops AI-powered software for medical imaging and treatment planning used by hospitals and clinics; long-term growth drivers include broader AI adoption in healthcare, demographic trends increasing imaging demand, and market and regulatory expansion. Investors may find the company attractive for its technology focus and potential for scalable recurring revenue if clinical adoption and commercialization progress.

Principal risks include commercialization and execution risk, regulatory approval and reimbursement uncertainty, competition and the need for additional funding.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.20
Dividend Yield
-
Revenue TTM
1.90M
Revenue Per Share
0.01
Gross Profit TTM
0.71M
Debt / Equity
0.01
ROE
-53.66%
Net Debt
-2.25M
ROCE
-63.73%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -6.34M -6.26M -2.88M -5.39M -5.99M
Net income -6.34M -6.38M -4.92M -5.39M -5.99M
Selling general administrative - 0.87M 0.82M 4.22M 4.54M
Selling and marketing expenses - 0.28M 0.29M - 0.29M
Gross profit -4.02M -0.09M 0.52M 0.52M 0.05M
Reconciled depreciation - 0.13M 0.20M 0.39M 0.26M
Ebit -6.77M -6.40M -3.09M -4.74M -5.97M
Ebitda -6.69M -6.27M -2.58M -3.83M -5.71M
Depreciation and amortization 0.08M 0.13M 0.51M - 0.26M
Operating income -6.77M -6.20M -2.86M -4.90M -5.97M
Other operating expenses 8.20M 6.76M 3.80M 0.06M 6.34M
Interest expense 0.01M 0.01M 0.10M 0.46M 0.01M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.14M 0.01M 0.49M 0.01M
Net interest income - 0.13M 0.22M -0.46M -0.01M
Extraordinary items - -0.11M -2.05M - -
Income tax expense - - 2.05M - 0.32M
Total revenue 1.43M 0.56M 0.93M 1.03M 0.05M
Total operating expenses 2.75M 6.11M 3.38M - 6.34M
Cost of revenue 5.45M 0.64M 0.42M 0.51M -
Total other income expense net 0.43M -0.06M -0.01M 0.43M 0.30M
Net income from continuing ops - -6.26M -2.88M -4.68M -5.99M
Net income applicable to common shares - -6.38M -4.92M -5.39M -5.99M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 11.24M 14.21M 2.35M 3.00M 2.14M
Intangible assets - - - 0.27M 0.45M
Other current assets 0.09M 0.07M 0.68M - -
Total liab 0.70M 1.11M 0.91M 2.94M 0.39M
Total stockholder equity 10.54M 13.10M 1.44M 0.06M 1.75M
Other current liab 0.17M 0.46M 0.64M 0.01M 0.19M
Common stock 32.66M - 16.43M 11.98M 9.53M
Capital stock - 29.92M - 11.98M 9.53M
Retained earnings -30.22M -23.88M -20.90M -16.14M -11.15M
Good will - - - 0.78M -
Other assets - - 0.00M - -
Cash 2.36M 13.68M 1.45M 0.69M 1.14M
Total current liabilities 0.61M 1.11M 0.91M 2.70M 0.37M
Current deferred revenue - - 0.00M - -
Net debt -2.25M - -1.23M 1.08M -1.05M
Short term debt 0.02M - 0.22M 2.24M 0.07M
Short long term debt - - - 1.77M 0.00M
Short long term debt total 0.11M - 0.22M - 0.09M
Other stockholder equity - - - 4.22M 3.37M
Property plant equipment - - - 0.87M 0.13M
Total current assets 11.01M 14.06M 2.20M 0.98M 1.31M
Long term investments - - - 0.23M 0.24M
Net tangible assets - - - -0.98M 1.29M
Short term investments 7.70M - - - -
Net receivables 0.86M 0.06M 0.06M 0.07M 0.14M
Long term debt - - - 0.14M -
Inventory - - - 0.13M -
Accounts payable 0.42M 0.26M 0.05M 0.16M 0.12M
Accumulated other comprehensive income 8.10M - 5.91M - 3.37M
Non currrent assets other 0.01M - 0.11M - -
Non current assets total 0.22M 0.14M 0.15M 2.21M 0.83M
Capital lease obligations - - - 0.31M 0.08M
Long term debt total - - - 0.23M 0.02M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.09M -0.00M -0.63M -0.01M
Change to liabilities - - - 0.70M -0.01M
Total cashflows from investing activities 5.37M 0.09M -0.00M -0.64M -0.02M
Net borrowings - -0.21M -1.67M 1.10M -0.07M
Total cash from financing activities 1.67M 14.48M 3.21M 2.65M -0.07M
Change to operating activities - - - 0.00M 0.04M
Net income -6.34M -6.38M -4.92M -5.39M -5.99M
Change in cash -11.32M 12.22M 0.76M -0.45M -3.00M
Begin period cash flow 13.68M 1.46M 0.69M 1.14M 4.14M
End period cash flow 2.36M 13.68M 1.46M 0.69M 1.14M
Total cash from operating activities -5.30M -2.34M -2.44M -2.46M -2.91M
Issuance of capital stock - 14.72M 5.17M 1.55M -
Depreciation 0.08M 0.13M 0.20M 0.39M 0.26M
Other cashflows from investing activities 0.17M 0.12M 0.07M -0.61M -0.01M
Change to inventory - - -0.18M - -
Change to account receivables -0.63M -0.13M -0.00M -0.10M 0.07M
Sale purchase of stock - 14.72M 5.17M 1.55M 0.00M
Other cashflows from financing activities -0.01M -0.21M -0.29M 0.42M -0.07M
Change to netincome - - - 1.94M 2.72M
Capital expenditures 0.14M 0.03M 0.07M 0.02M 0.01M
Change in working capital -1.17M -0.16M -0.16M 0.42M 0.38M
Stock based compensation - 3.28M - - -
Other non cash items 2.13M 0.78M 2.65M - -
Free cash flow -5.45M -2.37M -2.51M -2.53M -0.01M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SHG
Singular Health Group Ltd
0.01
2.50%
0.20 - - 37.76 6.50 40.98 -1.47
PME
Pro Medicus Ltd
-4.52
2.18%
202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd
-0.06
2.53%
2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd
0.12
3.30%
3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd
-0.14
3.91%
3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Singular Health Group Ltd

Singular Health Group Ltd, operates as a healthcare technology company in Australia. The company Volumetric Rendering Platform, a proprietary technology that enhances the visualization of patient anatomy and health issues by converting 2D images from CT, MRI, and PET scans into 3D models. It also provides Medical File Transfer Protocol, a technology that streamlines the access, sharing, and storage of medical images, such as CT, MRI, and PET scans across electronic devices and healthcare providers. In addition, the company offers AI in the Cloud that enhances medical imaging by integrating AI models. Further, it provides 3DICOM MD for healthcare professionals; 3DICOM EDU and XR for academics and researchers; and 3DICOM Patient for patients. Additionally, the company is involved in development and commercialization of the 3DICOM platform; enterprise healthcare imaging/interoperability solutions; education applications; and associated regulatory and product-development activities. Singular Health Group Ltd was incorporated in 2020 and is based in Leederville, Australia.

E3/661 Newcastle Stree, Leederville, WA, Australia, 6007

61 1300 167 795

Name Title Year Born
Mr. Thomas Hanly B.A. MD, CEO & Director NA
Mr. James Hill Chief Operating Officer NA
Dr. Kwang Guan Tay Ph.D. Exec. Director of Innovation and Education & Director NA
Mr. Steven Douglas Wood B.Com, B.Com., BCom., C.A., CA Company Sec. NA
Mr. Thomas Morrell Chief Technology Officer NA
Mr. Denning Chong Co-Founder, MD, CEO & Director NA
Mr. Steven Douglas Wood B.Com, B.Com., BCom., C.A., CA Company Secretary NA
Ms. Kyla Garic B.Com., C.A. Chief Financial Officer NA
Mr. Denning Chong Co-Founder, MD, CEO & Director NA
Mr. Steven Douglas Wood B.Com, B.Com., BCom., C.A., CA Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…